In the single-mouse orthotopic pancreatic xenograft experiments using 6741, 4636, 4535, and 4911 tumor models, combination treatment with GIPC-1 siRNA and GEM consistently demonstrated superior antitumor efficacy compared to individual treatments or controls (Figure S4). The gene discussed is GIPC1; the disease is neoplasm.